HEALTHBRPROUD BATON ROUGE
Pennington Biomedical seeks volunteers for weight-loss study
Researchers at the Pennington Biomedical Research Center are conducting a clinical trial to study the effects of a new hormone-based drug on metabolism and weight loss in adults with a BMI of 30 or higher.
Mentioned
Related Signal
Adjacent reporting
- New weight-loss drug Retatrutide showing stronger results than current options
- Experimental obesity drug outperforms traditional weight-loss treatments in early research
- Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
- Ozempic delivers major weight loss in adults over 65, study finds